Skip to main content
Caplight Logo









Macomics

Macomics

Private
EdinburghHealthcare & Life Scienceshttps://macomics.com

Last Round

Seed

Jul 29, 2021

Total Funding Raised

$9.97M

Company Overview

Macomics operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Seed round in July 2021.

Macomics is a biotechnology company developing precision medicines designed to modulate macrophages for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Macomics Comparables

Compare Macomics with similar companies based on industry and business-model similarity.

Macomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Verseau Therapeutics
78%
United Immunity, Co., Ltd.
78%
LTZ Therapeutics
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Macomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 29, 2021
SeedJul 14, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Steve M.

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Macomics Investors

Notable investors and investment history

Macomics investors
InvestorRounds
Epidarex CapitalSeed
Old College CapitalSeed
Scottish Investment Bank (Scottish Enterprise)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2025

    Monthly visitors increased 347% MoM.

  • Jul 29, 2021

    $6M raised in Seed round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Macomics Filings

Explore SEC and related filing metadata, where available.

Macomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Macomics's valuation, stock price, and market status.

Is Macomics a public or private company?

Macomics is a private company.

What is the current stock price of Macomics?

Macomics is a private company, so its shares have no public market price. Caplight tracks Macomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Macomics worth (valuation)?

Valuation information for Macomics is not publicly available.

Can I buy Macomics stock?

Macomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Macomics's last funding round?

Macomics's most recent funding round was Seed on July 29, 2021.

Who are the main investors in Macomics?

Key investors in Macomics include Epidarex Capital.

Will Macomics IPO soon?

No public IPO plans have been announced for Macomics.

How can I track Macomics secondary market activity?

Caplight tracks bids, offers, and trades in Macomics's shares on secondary markets.

Firmographic Details

HeadquartersEdinburgh
Employee Range18
Year Founded2018
Last FundingJul 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?